These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28987544)

  • 21. Retrograde inspection
    Rath T; Pfeifer L; Neufert C; Kremer A; Leppkes M; Hoffman A; Neurath MF; Zopf S
    World J Gastroenterol; 2020 Apr; 26(16):1962-1970. PubMed ID: 32390706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Risk of Metachronous Advanced Colorectal Neoplasia Rises in Parallel with an Increasing Number of High-Risk Findings at Baseline.
    Lee SM; Kim JH; Sung IK; Hong SN
    Gut Liver; 2015 Nov; 9(6):741-9. PubMed ID: 25963078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ≥3 Nonadvanced Adenomas are More Common in the Era of Contemporary Colonoscopy and Not Associated With Metachronous Advanced Neoplasia.
    Rouphael C; Lopez R; McMichael J; Burke CA
    J Clin Gastroenterol; 2021 Apr; 55(4):343-349. PubMed ID: 32427796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of adenoma detection rate on detection of advanced adenomas and endoscopic adverse events in a study of over 200,000 screening colonoscopies.
    Penz D; Ferlitsch A; Waldmann E; Irina G; Daniel P; Asaturi A; Hinterberger A; Majcher B; Szymanska A; Trauner M; Ferlitsch M
    Gastrointest Endosc; 2020 Jan; 91(1):135-141. PubMed ID: 31499041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of Developing Metachronous Advanced Colorectal Neoplasia After Polypectomy in Patients With Multiple Diminutive or Small Adenomas.
    Kim NH; Jung YS; Lee MY; Park JH; Park DI; Sohn CI
    Am J Gastroenterol; 2019 Oct; 114(10):1657-1664. PubMed ID: 31211708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anatomic and advanced adenoma detection rates as quality metrics determined via natural language processing.
    Gawron AJ; Thompson WK; Keswani RN; Rasmussen LV; Kho AN
    Am J Gastroenterol; 2014 Dec; 109(12):1844-9. PubMed ID: 24935271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
    Wong JCT; Chiu HM; Kim HS; Byeon JS; Matsuda T; Kobayashi N; Wu DC; Ong DE; Sung JJY;
    Gastrointest Endosc; 2019 Mar; 89(3):607-613.e1. PubMed ID: 30452915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopists with low adenoma detection rates benefit from high-definition endoscopy.
    Waldmann E; Britto-Arias M; Gessl I; Heinze G; Salzl P; Sallinger D; Trauner M; Weiss W; Ferlitsch A; Ferlitsch M
    Surg Endosc; 2015 Feb; 29(2):466-73. PubMed ID: 25005016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term cumulative incidence of metachronous advanced colorectal neoplasia after colonoscopy and a novel risk factor: a cohort study.
    Omata F; Deshpande GA; Suzuki H; Hayashi K; Ishii N; Matoba K; Ohmuro A; Rai F; Takashima M; Fukuda K; Masuda K; Kumakura Y
    Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1341-1347. PubMed ID: 34402471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors associated with colorectal flat adenoma detection.
    Nicolás-Pérez D; Parra-Blanco A; Gimeno-García AZ; Ortega-Sánchez JA; Carrillo-Palau M; Jiménez-Sosa A; Quintero-Carrion E
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):302-8. PubMed ID: 23169312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between adenoma detection rate and novel quality indicators for screening colonoscopy. A proposal for quality measures tool kit.
    Abdelfatah MM; Elhanafi S; Zuckerman MJ; Othman MO
    Scand J Gastroenterol; 2017 Oct; 52(10):1148-1157. PubMed ID: 28643529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Hassan C; Senore C; Radaelli F; De Pretis G; Sassatelli R; Arrigoni A; Manes G; Amato A; Anderloni A; Armelao F; Mondardini A; Spada C; Omazzi B; Cavina M; Miori G; Campanale C; Sereni G; Segnan N; Repici A
    Gut; 2017 Nov; 66(11):1949-1955. PubMed ID: 27507903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between adenoma detection rate and advanced adenoma detection rate].
    Lee SY; Kim NH; Chae HB; Han KJ; Lee TH; Jang CM; Yoo KM; Jung YS; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Park DI
    Korean J Gastroenterol; 2014 Jul; 64(1):18-23. PubMed ID: 25073667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining Benchmarks for Adenoma Detection Rate and Adenomas Per Colonoscopy in Patients Undergoing Colonoscopy Due to a Positive Fecal Immunochemical Test.
    Hilsden RJ; Bridges R; Dube C; McGregor SE; Naugler C; Rose SM; Rostom A; Heitman SJ
    Am J Gastroenterol; 2016 Dec; 111(12):1743-1749. PubMed ID: 27725649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.
    Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW
    Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for advanced colorectal adenomas: a pooled analysis.
    Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
    Kligman E; Li W; Eckert GJ; Kahi C
    Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenoma Detection Rate in Colonoscopy: Is Indication a Predictor?
    Yang PF; Wong SW
    Surg Laparosc Endosc Percutan Tech; 2016 Apr; 26(2):156-61. PubMed ID: 26813239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.